Neuro-Oncology: The Podcast
A podcast by Neuro-Oncology
99 Episoade
-  Targeted therapy for BRAF-mutant pediatric gliomaPublicat: 17.06.2022
-  Early/evolving IDH wild-type glioblastomaPublicat: 20.05.2022
-  PI3K signaling in IDH mutant gliomasPublicat: 06.05.2022
-  Cell-free DNA from CSF in pediatric, adolescent and young adult patientsPublicat: 22.04.2022
-  Molecular determinants of neurocognitive deficits in gliomaPublicat: 08.04.2022
-  H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline gliomaPublicat: 25.03.2022
-  Clinical trial accrual for women and minorities in neuro-oncologyPublicat: 11.03.2022
-  The clinical utility of next generation sequencing for IDHwt glioblastomaPublicat: 11.02.2022
-  Trabectedin for recurrent grade 2 or 3 meningiomasPublicat: 28.01.2022
-  Glioblastoma cell heterogeneity and plasticityPublicat: 14.01.2022
-  Moleculary integrated grading for meningiomaPublicat: 24.12.2021
-  BOLD fMRI in IDH mutant gliomasPublicat: 10.12.2021
-  Glioblastoma subtypes and response to DasatinibPublicat: 26.11.2021
-  Resection for recurrent brain metastasesPublicat: 12.11.2021
-  Incidental MeningiomasPublicat: 29.10.2021
-  Immunosuppression in IDH mutant gliomasPublicat: 15.10.2021
-  Immunotherapy for melanoma brain metastasesPublicat: 01.10.2021
-  DNA methylation profiles within the CATNON trialPublicat: 17.09.2021
-  18F FET PET in childhood CNS tumorsPublicat: 03.09.2021
-  Checkpoint blockade in atypical meningiomasPublicat: 20.08.2021
Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.
